JPS6425728A - Nootropic (noesis improving agent) - Google Patents

Nootropic (noesis improving agent)

Info

Publication number
JPS6425728A
JPS6425728A JP62177959A JP17795987A JPS6425728A JP S6425728 A JPS6425728 A JP S6425728A JP 62177959 A JP62177959 A JP 62177959A JP 17795987 A JP17795987 A JP 17795987A JP S6425728 A JPS6425728 A JP S6425728A
Authority
JP
Japan
Prior art keywords
active ingredient
tablet
histidylprolinamide
nootropic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62177959A
Other languages
Japanese (ja)
Other versions
JPH0641420B2 (en
Inventor
Kiyoshi Kimura
Yojiro Ukai
Takashi Ogasawara
Yutaka Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP62177959A priority Critical patent/JPH0641420B2/en
Publication of JPS6425728A publication Critical patent/JPS6425728A/en
Publication of JPH0641420B2 publication Critical patent/JPH0641420B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a nootropic agent containing a histidylprolinamide derivative as an active ingredient. CONSTITUTION:A histidylprolinamide derivative shown by the formula (R is lower alkyl) is used as an active ingredient and pharmaceutically manufactured by a conventional procedure directly or by using an ordinary drug carrier to give the aimed substance. The aimed substance can be prepared into a dosage form such as dust, powder, tablet, sugar-coated tablet, capsule, granule, suspension, solution, syrup, drop or troche. Injection contains preferably 0.01-1% of the compound shown by the formula and tablet contains 0.001-1% of the compound. A daily dose per adult is 0.01-50mg, preferably 0.1-10mg calculated as the active ingredient and administered dividedly several times.
JP62177959A 1987-04-08 1987-07-16 Nootropic agent Expired - Lifetime JPH0641420B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62177959A JPH0641420B2 (en) 1987-04-08 1987-07-16 Nootropic agent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62-86405 1987-04-08
JP8640587 1987-04-08
JP62177959A JPH0641420B2 (en) 1987-04-08 1987-07-16 Nootropic agent

Publications (2)

Publication Number Publication Date
JPS6425728A true JPS6425728A (en) 1989-01-27
JPH0641420B2 JPH0641420B2 (en) 1994-06-01

Family

ID=26427537

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62177959A Expired - Lifetime JPH0641420B2 (en) 1987-04-08 1987-07-16 Nootropic agent

Country Status (1)

Country Link
JP (1) JPH0641420B2 (en)

Also Published As

Publication number Publication date
JPH0641420B2 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
ES8307095A1 (en) Pharmaceutical Formulation.
IL77186A0 (en) Pharmaceutical insulin composition
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
PL318649A1 (en) Preparation to be administered by inhalation
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
ES2001706A6 (en) Peptide derivatives, process for the production thereof and pharmaceutical compositions containing same.
FR2698788B1 (en) Effervescent pharmaceutical composition containing ibuprofen and process for its preparation.
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
JPS57109721A (en) Carcinostatic agent
JPS6416721A (en) Antioxidant
JPS6425728A (en) Nootropic (noesis improving agent)
JPS57140716A (en) Antiallergic agent
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
ES8603829A1 (en) Medicines based on piperidine derivatives, piperidine derivatives and process for their preparation.
JPS643121A (en) Remedy for endometriosis
JPS6440426A (en) Antitumor agent
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS6466125A (en) Remedy for gastritis
JPS54132239A (en) Anti-tumor agent
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
GB9420748D0 (en) 1,5 benzodiazepine derivatives
JPS6452723A (en) Suppressant against multiplication of aids virus